D. Testelmans (Leuven, Belgium), E. Schwarz (Zürich, Switzerland)
Effectiveness of an integrated hospital-primary care lifestyle change program in the treatment of obstructive sleep apnea syndrome and obesity
N. Salord Oleo (Hospitalet de LLobregat, Spain), C. Alves (Hospitalet de Llobregat, Spain), E. Prado (Hospitalet de Llobregat, Spain), S. Pérez (Hospitalet de Llobregat, Spain), M. Calvo (Hospitalet de Llobregat, Spain), R. Torta (El Prat de Llobregat, Spain), M. González (Hospitalet de Llobregat, Spain), L. Rubio (Hospitalet de Llobregat, Spain), A. Comabella (Hospitalet de Llobregat, Spain), R. Suárez (Hospitalet de Llobregat, Spain), M. Montserrat (Hospitalet de Llobregat, Spain), N. Vilarrasa (Hospitalet de Llobregat, Spain), C. Monasterio (Hospitalet de Llobregat, Spain)
|   |
Adherence to Positive Airways Pressure therapy in patients with sleep apnea and comorbid psychiatric diseases.
A. Kallianos (Athens, Greece), P. Nikolaidis (Athens, Greece), D. Stamatelakis (Athens, Greece), C. Klamenakou (Athens, Greece), N. Economou (Athens, Greece), P. Steiropoulos (Alexandroupolis, Greece), G. Trakada (Athens, Greece)
| |
Association of positive airway pressure adherence with clinical outcomes in patients with type 2 diabetes and obstructive sleep apnea
I. Bouloukaki (Heraklion (Crete), Greece), M. Fanaridis (Heraklion (Crete), Greece), G. Stathakis (Heraklion (Crete), Greece), C. Ermidou (Heraklion (Crete), Greece), K. Lyroni (Heraklion (Crete), Greece), E. Mavroudi (Heraklion (Crete), Greece), V. Moniaki (Heraklion (Crete), Greece), I. Tsiligianni (Heraklion (Crete), Greece), S. Schiza (Heraklion (Crete), Greece)
| |
Outcomes of CPAP therapy in Down syndrome – the population-based DISCOVERY study
A. Palm (Uppsala, Sweden), M. Svensson (Uppsala, Sweden), M. Ekström (Lund, Sweden), J. Sundh (Örebro, Sweden), M. Ljunggren (Uppsala, Sweden), L. Grote (Göteborg, Sweden)
| |
The effect of 2 years of CPAP therapy on métabolic comorbidities in OSAS
M. Loukil Ben Ali (Nabeul, Tunisia), H. Khaoula (nabeul, Tunisia), N. Abid (nabeul, Tunisia), M. Ben Ali (nabeul, Tunisia), H. Ghrairi (nabeul, Tunisia)
| |
Short-term continuous positive air pressure treatment: effects on quality of life and sleep in patients with obstructive sleep apnea
L. Kondrataviciene (Kaunas, Lithuania), S. Miliauskas (Kaunas, Lithuania)
| |
Long term outcomes in CPAP-treated sleep apnea patients: Impact of blood pressure responses after CPAP initiation and treatment adherence
A. Bocoum (Grenoble, France), S. Bailly (Grenoble, France), M. Joyeux-Faure (Grenoble, France), S. Baillieul (Grenoble, France), F. Arbib (Grenoble, France), C. Kang (Grenoble, France), T. Ngo (Grenoble, France), P. Boutouyrie (Grenoble, France), R. Tamisier (Grenoble, France), J. Pépin (Grenoble, France)
| |
Nasal polyposis is a risk factor for non-adherence to CPAP – the DISCOVERY study
C. Bengtsson (Uppsala, Sweden), L. Grote (Gothenburg, Sweden), M. Ljunggren (Uppsala, Sweden), M. Ekström (Lund, Sweden), A. Palm (Uppsala, Sweden)
| |
A prospective study of factors that predict compliance with Continuous Positive Airway Pressure (CPAP) in patients with Obstructive Sleep Apnoea (OSA)
A. Ali (Stoke on Trent, United Kingdom), Q. Khan (Nottingham, United Kingdom), A. Hough (Birminghamon Trent, United Kingdom), M. Marathe (Stoke-on-Trent, United Kingdom), I. Hamigi (Hull, United Kingdom), A. Bain (Stoke-On-Trent, United Kingdom), A. Thomas (Stoke-On-Trent, United Kingdom)
| |
Predicting adherence to continuous positive airway pressure in patients with obstructive sleep apnea syndrome through machine learning
M. Pacheco Pereira (Seixal, Portugal), R. Ribeiro (Lisboa, Portugal)
| |
Persistent inspiratory flow limitation during positive airway pressure therapy
N. Skjodt (Lethbridge (AB), Canada), R. Platt (Calgary (AB), Canada)
| |
Telemedicine home CPAP titration and follow-up in the COVID-19 scenario
J. Bordas Martinez (Hospitalet de Llobregat (Barcelona), Spain), E. Fontanilles Arbones (Hospitalet de Llobregat (Barcelona), Spain), N. Salord (Hospitalet de Llobregat (Barcelona), Spain), E. Prado Gala (Hospitalet de Llobregat (Barcelona), Spain), M. Calvo Sánchez (Hospitalet de Llobregat (Barcelona), Spain), S. Santos (Hospitalet de Llobregat (Barcelona), Spain), C. Monasterio (Hospitalet de Llobregat (Barcelona), Spain)
| |
Efficacy of VAUTO ventilation in OSA patients resistant to CPAP
P. Tondo (Foggia, Italy), R. Trentin (Pavia (PV), Italy), C. Pronzato (Pavia (PV), Italy), S. Arcovio (Pavia (PV), Italy), F. Fanfulla (Pavia (PV), Italy)
| |
Auto-BiPAP switch in OSA patients: can it be done successfully?
P. Tondo (Foggia, Italy), C. Pronzato (Pavia (PV), Italy), I. Risi (Pavia (PV), Italy), N. D'Artavilla Lupo (Pavia (PV), Italy), F. Fanfulla (Pavia (PV), Italy)
| |
Reboxetine improves pharyngeal collapsibility and respiratory control in obstructive sleep apnoea.
T. Altree (Adelaide, Australia), A. Aishah (Sydney, Australia), K. Loffler (Adelaide, Australia), R. Grunstein (Sydney, Australia), D. Eckert (Adelaide, Australia)
| |
Effect of 5 mg of Oxybutynin and 6 mg of Reboxetine on obstructive sleep apnea severity
M. Berger (Lausanne, Switzerland), R. Dussez (Lausanne, Switzerland), N. Marchi (Lausanne, Switzerland), G. Solelhac (Lausanne, Switzerland), B. Bradley (Lausanne, Switzerland), G. Lecciso (Lausanne, Switzerland), J. Haba-Rubio (Lausanne, Switzerland), F. Siclari (Lausanne, Switzerland), R. Heinzer (Lausanne, Switzerland)
| |
Effectiveness of acetazolamide in patients with moderate obstructive sleep apnea and obesity
I. Andreieva (Zaporizhia, Ukraine)
| |
Effect of sulthiame on cardiopulmonary coupling assessed sleep quality in OSA patients – a RCT
K. Theliander (Gothenburg, Sweden), J. Hedner (Gothenburg, Sweden), C. Strassberger (Gothenburg, Sweden), K. Stenlöf (Gothenburg, Sweden), L. Grote (Gothenburg, Sweden), D. Zou (Gothenburg, Sweden)
| |
Robotic beds for the treatment of positional obstructive sleep apnoea – a randomised cross-over pilot trial
M. Meszaros (Zurich, Switzerland), A. Breuss (Zurich, Switzerland), E. Wilhelm (Zurich, Switzerland), R. Riener (Zurich, Switzerland), M. Kohler (Zurich, Switzerland), E. Schwarz (Zurich, Switzerland)
| |
Late Breaking Abstract - Sulthiame induced carbonic anhydrase inhibition is associated with improvement of nocturnal oxygenation in OSA patients
A. Komai (Gothenburg, Sweden), S. Musovic (Gothenburg, Sweden), L. Grote (Gothenburg, Sweden), K. Stenlöf (Gothenburg, Sweden), E. Hoff (Gothenburg, Sweden), D. Zou (Gothenburg, Sweden), J. Hedner (Gothenburg, Sweden)
| |